E N D
1. New York HubEH&S Focus
2. The New York Hub A profile of our institution and our programs
Overview of hub collaborators
Biomanufacturing along the I-90 Health Sciences Corridor
The Environmental Health and Safety Curriculum and Action Plan
3. FLCC and the New York Hub
5. A.S. Biotechology Gateway courses (BIO I and II, CHM I and II)
Advanced (Cell, Micro, Genetics)
Techniques (Genetics lab, Bacteriological, Electrophoresis, Genetics Research/PCR, Cell and Tissue, Spectrophotometric, Plant microprop)
Transfer (Organic I,II; Calc I level of math)
Credits:
67 minimum (Algebra/Pre-calc sequence)
68 recommended (Pre-calc/Calc I sequence)
73 for transfer (inclusion of Organic I and II)
6. Principles of Biomanufacturing
9. Danisco acquired Genencor in 2005
Dansico becomes the second largest supplier of industrial enzymes in the world.
The Rochester Center for Development and Commercialization (RCDC) – enzymes
The Rochester Therapeutics Production Center (RTPC) – cGMP biopharmaceuticals – Health Care Division
10. Celltech - North American commercialization and manufacturing center
40-acre site includes 400,000 sq. ft. of modern manufacturing space
Biopharmaceuticals for treatment of
Attention deficit hyperactivity disorder (ADHD)
Obesity
Respiratory diseases
Bronchitis, and allergic rhinitis
11. 90 plus acre campus.
large volume fermentation manufacturing
world-class chemical and biotechnology development laboratories
pilot and commercial manufacturing plants
pharmaceutical research laboratories.
Expansion Plan – “Project Hummingbird”
12. John Tabor, Ph.D. - Vice President Global Biotechnology and Third Party Manufacturing Strategy
Steven Lee, Ph.D. - Senior Director, Syracuse Biotechnology Development and Operations
Kirk Leister, Ph.D. - Director Analytical Biochemistry
Michael Munster, Ph.D. - Director Biologics Quality Assurance and Quality Control, Syracuse
Tom Vanden Boom, Ph.D. - Director, Biotechnology Development
Alan Berry, Ph.D. - Director, Bioprocess Development
Les Mintzmyer - Director Syracuse Biotechnology Manufacturing Operations
John Hickey - Group Leader, Syracuse Biologics Project Management
Sallie Bittner - Director of Human Resources, Syracuse
Dave Lapinski - EHS Associate Director, Third Party Manufacturing/In-Licensing Programs.
13. CAS LLC Alzheimer’s disease therapies.
Koning Corporation 3-D visualization of breast tumors.
LAGeT Inc. gene therapy in musculoskeletal indications.
OyaGen Inc. HIV therapeutics.
Pathologics Inc. biological diagnostic systems.
RTek Medical Systems LLC prostate cancer therapy.
Socratech LLC diagnostic and therapeutic approaches to Alzheimer’s disease.
Vaccinex Inc. therapeutic antibody discovery.
VirtualScopics LLC’s CT scans conversion into 3-D color images. URMC “engine running”
14. The prototypical Rochester biotechnology company
URMC spin-off
proprietary ACTIVMAB antibody discovery technology
library-based antibody discovery technology
Express complete, fully functional antibodies in mammalian cells
Antibody therapeutics
Product pipeline
C35 for breast cancer, BVX-10 for inflammation, BVX-20 for oncology
Long-range view of manufacturing “in house.”
33,000 sq. ft. Rochester facility employs 46 individuals
$32 million in venture and $10 million in grants
15. EHS Curriculum Pre-requisites Math skills: up to, and including college-level algebra
Basic computer skills (Word, Excel, PowerPoint)
A basic understanding of chemical principles concentration expressions, pH, acids, bases, buffers)
16. Core “platform” Principles Knowledge of EHS documents and various forms of documentation
A survey of the various standards applied by EHS professionals.
An understanding of all of the ways that hazards are communicated to employees in the biomanufacturing environment.
Understanding permits: reading, designing, and utilizing permits
Understanding of waste streams, recycling, and Hazardous Waste Operations (HAZWOPER)
Accident Investigation and principles of accident investigation (root cause analysis)
17. A focus on regulations Hazardous material management (EPA, State Environmental Agencies)
Hazard communication (OSHA)
Spill Prevention (EPA, State Environmental Departments)
Process safety (OSHA)
Wastewater regulations (EPA, State Environmental Agencies)
Ergonomics (OSHA)
How to read write and utilize safe work permits, confined space permits (OSHA)
Lock Out Tag Out (LOTO) standards and procedures (OSHA)
Hazard Communication (OSHA)
HAZWOPER – Hazardous Waste Operations and Emergency Response (OSHA, EPA, State Environmental Agencies, DOT)
Means of Egress (OSHA)
18. Pedagogical Approach The pedagogical approach will utilize a combination of case studies and hands-on activities. The case studies will create the context for the hands-on activities and will provide the core critical thinking challenges.
19. Case #1: Confined Spaces Confined Space Entry Scenario
Utilize a Standard Operating Procedure as part of a simulated CSE Program
Calibration and utilization of gas monitoring instrumentation
Lock-out/Tag-out activity
Working with safety permits
20. Case #2: HAZWOPER Program Hazardous Waste Operations and Emergency Response
develop a basic HAZWOPER program for a new biomanufacturing facility (their college).
students will explore the elements of existing plans
Learn how HAZWOPER is the intersection of three Federal regulatory agencies (EPA, OSHA, DOT).
Explore the two main objectives of HAZWOPER Operations:
Control or eliminate the potential hazards and/or losses.
Protect the health and safety of workers, the public, and the environment.
21. Case #3: Accident Investigation Employ accident investigation techniques to help determine the cause of the accident (root cause analysis).
Interrupted case method will be applied
simulates the collection of information and analysis of data collected during the investigation.
Students will then be challenged with the task of producing an investigation of their report in a specified format.